Patent details

Basic Information

Publication number:

EP3266463

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP171888571

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

HEMOGLOBIN COMPOSITIONS

French Title of Invention:

COMPOSITIONS D'HÉMOGLOBINE

German Title of Invention:

HÄMOGLOBINZUSAMMENSETZUNGEN

SPC Number:

Dates

Filing date:

09/06/2010

Grant date:

13/12/2023

EP Publication Date:

10/01/2018

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/12/2023

EP B1 Publication Date:

13/12/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

09/06/2024

Expiration date:

09/06/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/12/2023

 

 

Name:

Prolong Pharmaceuticals, LLC

Address:

300 Corporate Court Suite B, South Plainfield, NJ 07080, United States (US)

Inventor

1

Name:

ABUCHOWSKI, Abraham

Address:

United States (US)

2

Name:

O'HARE, Keith

Address:

United States (US)

3

Name:

SLOSHBERG, Steven

Address:

United States (US)

Priority

Priority Number:

185547 P

Priority Date:

09/06/2009

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/42; A61K 9/00; A61K 9/08; A61K 47/02; A61K 47/60; A61P 9/10; A61P 7/00; A61P 7/06; A61P 7/08; A61P 9/00; A61P 17/02; A61P 35/00; A61P 39/06;

Publication

European Patent Bulletin

Issue number:

202350

Publication date:

13/12/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages